Famed cannabis breeding and lifestyle company DNA Genetics has partnered up with Israel-based medical cannabis company UNIVO Pharmaceuticals UNVO to bring its products to the Israeli medical cannabis market.
The plan is to bring DNA Genetics’ vast catalogue of high-quality strains to Israel and develop medical and science-based cannabis products using UNIVO’s advanced farming infrastructure to aid consumers in Israel and the world.
“UNIVO Pharmaceuticals is the perfect partner for DNA Genetics as we expand into the Israeli medical cannabis market. By introducing our world-class genetics to Israel, we can continue to develop additional medicinal cannabis products overseas and help the world realize the potential of cannabis for overall health and well-being,” Rezwan Khan, president of DNA Genetics, told Benzinga.
Latest Startup Investment Opportunities:
Details on the deal will follow soon.
Encuentra nuestro contenido en Español en El Planteo:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
